Therefore, our study suggests that manipulation of mitochondrial fusion component Mfn2 could be a potentially promising therapeutic strategy to forestall retinal aging and aged-associated retinal degeneration; yet further investigations are required to explore the practical approach. The gene discussed is MFN2; the disease is retinal degeneration.